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Abstract
Plasma membranes in eukaryotic cells display asymmetric lipid distributions with aminophospholipids concentrated in the
inner leaflet and sphingolipids in the outer leaflet. This unequal distribution of lipids between leaflets is, amongst several
proposed functions, hypothesized to be a prerequisite for endocytosis. P4 ATPases, belonging to the P-type ATPase
superfamily of pumps, are involved in establishing lipid asymmetry across plasma membranes, but P4 ATPases have not
been identified in plant plasma membranes. Here we report that the plant P4 ATPase ALA1, which previously has been
connected with cold tolerance of Arabidopsis thaliana, is targeted to the plasma membrane and does so following
association in the endoplasmic reticulum with an ALIS protein b-subunit.
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Introduction
The plasma membrane (PM) is the outermost barrier of a cell
and is responsible for the exchange of matter and information
between its exterior and the interior. First recently it has been
acknowledged that the asymmetric distribution of lipids between
the two leaflets of the plasma membrane is important for its proper
function. In animal cells, the aminophospholipids phosphatidyl-
serine and phosphatidylethanolamine (PE) are in general seques-
tered in the inner leaflet of the plasma membrane, whereas
sphingomyelin and glycosphingolipids are enriched in the outer
leaflet [1,2]. Amongst other features, asymmetric transversal
distribution of phospholipids, sphingolipids, and free sterols
between the cytosolic and apoplastic (exoplasmic) leaflets is
required for maintaining a low permeability to solutes [3,4].
Among lipids, phosphatidylserine in particular is observed to
distribute unevenly between the two leaflets [5–7]. The phospha-
tidylserine asymmetry and its regulation is considered important to
cellular processes such as cell-cell recognition [8], endo- and
exocytosis [1], regulation of membrane surface potential [7] and
activation of membrane-bound enzymes [8,9] as indicated in
mammalian and yeast cells. Regulated loss of this asymmetric lipid
arrangement triggers a variety of physiological events including
apoptosis [10].
In the yeast Saccharomyces cerevisiae the plasma membrane
phospholipid asymmetry is influenced by ATP-dependent amino-
phospholipid translocases which constitute a subfamily, P4
ATPases, in the superfamily of P-type ATPase pumps [11–13].
S. cerevisiae has five P4 ATPases, among which two are localized in
the plasma membrane, namely Dnf1p and Dnf2p [14]. Loss of
Dnf1p and Dnf2p leads to an increased cell surface exposure of
endogenous phosphatidylserine, which is enhanced by additional
removal of the Golgi-localized P4 ATPase Drs2p [15]. Concurrent
with an altered phospholipid arrangement in the plasma
membrane, Ddrs2Ddnf1Ddnf2 cells exhibit a defect in the uptake
of the endocytic tracer FM4–64 and in the ligand-induced
internalization of a-factor receptor [14]. These results point to a
functional link between P-type ATPase-dependent lipid translo-
cation and budding of endocytic vesicles from the plasma
membrane.
P4 ATPases from protozoa and animal cells have also been
localized to the plasma membrane and shown to be involved in
phospholipid translocation across this membrane. These include
Leishmania donovanii LdMT, responsible for transporting the drug
miltefosine, a toxic choline ether lipid used in treatment of the
leishmaniasis disease [16,17], human ATP8B1, involved in a
severe liver disease in humans [18], and mouse FetA, involved in
formation of the acrosomal membrane in sperm cells [19]. In
addition to being involved in phospholipid flipping [18], ATP8B1
has a structural or signalling role in formation of microvilli in
intestinal cells, which appears to be independent on lipid transport
across the plasma membrane [20].
In plants, much less is known on the influence of lipids on the
functions of plasma membranes. It is generally assumed that a
transversal lipid asymmetry exists also in plant plasma membranes
[21,22], but the only analysis so far conducted on plant material
concluded that phosphatidylserine is the only phospholipid
asymmetrically distributed between the plasma membrane leaflets
[23]. The physiological significance of the phosphatidylserine
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asymmetry in plant plasma membranes is still unclear, and the
existence of phospholipid flippases in plant plasma membranes has
not yet been shown. Takeda and Kasamo [23] tried to detect
phospholipid flippase activity in the inside-out plasma membrane
vesicles created by Brij 58-treatment using (oleoyl-C12-NBD)-
phospholipids under various conditions, but could not find such an
activity, although phosphatidylserine was concentrated in the
inner leaflet.
In the model plant Arabidopsis, 12 P4 ATPase genes are
present [24]. Recently, we have demonstrated that two Arabi-
dopsis P4 ATPases ALA2 [25] and ALA3 [26], localize to the
prevacuolar compartment (PVC) and the Golgi apparatus,
respectively, and require a b-subunit (ALIS protein) for exit from
the endoplasmic reticulum (ER) and for transport of phospholip-
ids. A third Arabidopsis P4 ATPase, ALA1, has been character-
ized and shown to be able to transport lipids in yeast in the
absence of a co-expressed plant b-subunit [27]. However, the
subcellular localization of the protein was never investigated. In
this work, we demonstrate the ALA1 localizes to the plant plasma
membrane and has a strict requirement for a b-subunit to exit the
ER.
Results
ALA1 is Retained in the ER in the Absence of an ALIS
Protein
Transient expression in tobacco epidermal cells has been used
before to demonstrate that Arabidopsis P4 ATPases are retained in
the ER in the absence of an ALIS protein [25,26]. In order to
express and visualize ALA1 in tobacco, the genomic DNA
fragment corresponding to this protein was cloned and placed
under the control of its own promoter in a plant binary plasmid
containing an in-frame fusion with Green Fluorescent Protein
(GFP). However, this construct did not generate a detectable
fluorescent signal when infiltrated in tobacco cells. To overcome
this problem, the ALA1 genomic DNA was re-cloned into plasmids
of the pMDC series [28], which contain a double 35 S promoter
and allow for fusion of a GFP at each end of the protein of interest.
Both the N- and the C-terminally tagged ALA1 gDNA constructs
presented a clear fluorescent signal in membrane structures that
resembled the ER (Figure 1A and not shown). In order to confirm
the nature of these membranes, the ALA1 fusions were co-
expressed with a construct containing a Yellow Fluorescent
Protein (YFP) modified to include an HDEL ER retention signal
at the C-terminal end (Figure 1B). Co-localization of both
fluorescent proteins confirmed that ALA1 resides in the ER
membrane when expressed alone. Under our experimental
conditions, no bleed-through of the fluorescence signals was
detected (see Figure S1).
ALA1 Leaves the ER and Localizes to the Plasma
Membrane in the Presence of an ALIS Protein
In order to investigate whether ALA1 is an ER-resident protein
or whether it leaves the ER upon interaction with an ALIS b-
subunit, we transiently expressed the N-terminally GFP-tagged
ALA1 fusion in tobacco leaves in the presence of untagged
versions of three different ALIS proteins (ALIS1, ALIS3, ALIS5)
[26]. Co-expression with any ALIS protein resulted in localization
of the GFP fluorescence in membranes resembling either the
plasma membrane or the tonoplast (Figure 2A,C,E). In tobacco
epidermal cells, the vacuole occupies almost al the volume of the
cell, pressing all other organelles against the rigid cell wall. Thus,
under normal conditions, it is not possible to distinguish the
plasma membrane from the tonoplast, as they both run along the
cell wall. However, while the tonoplast can freely shrink under
hyperosmotic conditions, the plasma membrane is attached to the
cell wall at several contact points along the surface of the cell [29].
Thus, plasmolysis of the cells by addition of a hyperosmotic
solution allows distinguishing between the two membranes. When
the cells were plasmolyzed in the presence of a hyperosmotic
mannitol solution, several detachment areas flanked by attachment
points to the cell wall could be seen for the GFP-containing
membranes, which is to be expected for a plasma membrane
localization (Figure 2B,D,F). The same result was obtained for an
ALA1::GFP fusion (not shown).
ALIS Proteins are Localized to the Plasma Membrane
When Co-expressed with ALA1
Previously we have demonstrated that the localization determi-
nants for the ALA/ALIS complex reside in the a-subunit and that
ALIS proteins are localized to the same compartment as the ALA
protein they are co-expressed with. This was shown both for
Golgi-localized ALA3 [26] and for the prevacuolar compartment-
resident protein ALA2 [25]. To investigate if this was also the case
for plasma membrane-localized ALA1, C-terminally YFP-tagged
versions of ALIS1, ALIS3 and ALIS5 [26] were co-expressed with
GFP::ALA1 (Figure 3). In all cases, the fluorescent signals co-
localized to membranes resembling the plasma membrane. As
above, plasma membrane localization could be confirmed by
plasmolysis of the cells.
Heterologous Expression of ALA1 in a Ddrs2Ddnf1Ddnf2
Yeast Mutant Strain
Heterologous expression of plant proteins in the host S. cerevisiae
is a common tool to obtain protein for functional analysis and to
test whether gene expression in this host can functionally
complement mutations in related yeast genes. For this purpose,
a cDNA fragment codifying for haemagglutinin (HA)-tagged
ALA1 was cloned alone or together with Arg-Gly-Ser-His6
(RGSH6) tagged ALIS1, ALIS3 or ALIS5 into yeast plasmids
that contain a bi-directional GAL1-10 promoter, which allows for
expression of two proteins at the same time, and introduced into a
Ddrs2Ddnf1Ddnf2 yeast mutant strain.
To verify expression of ALA1 in yeast, we took advantage of the
epitope tags engineered at the N-terminal end of the proteins.
Immunodetection in total yeast membranes with antibodies raised
against the HA or the RGSH6 epitopes showed that ALA1 is not
expressed to detectable levels (Figure 4A), while clear signals could
be seen for HA-tagged ALA3 (used as a positive control) and for all
RGSH6-tagged ALIS proteins. In order to increase the level of
expression, we searched for genetic elements in the introduced
cDNA that could possibly affect negatively heterologous expres-
sion in yeast and identified a putative transcription termination
signal located about 300 amino acid residues before the stop codon
of ALA1 (see Figure S2). Using an overlapping PCR strategy, this
transcription termination site was removed from the cDNA
sequence. The new ALA1 version, ALA1noTT, was expressed
in yeast, both in untagged or tagged versions, alone or together
with RGSH6-tagged ALIS1, ALIS3 and ALIS5. Following this
approach, the HA-tagged version of ALA1noTT was also not
detectable in total yeast membranes (Figure 4A).
Next, we used a graphical codon usage analyser to identify
rare codons that might result in low levels of expression of ALA1
in S. cerevisiae. Based on the results of this analysis, five codons
codifying for arginine were mutated from CGG to AGA or
AGG, generating a yeast-enhanced ALA1 (yeALA1) (Figure S2).
Simultaneously, we aimed at increasing expression levels by
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modifying the GAL1 galactose-inducible promoter contained in
our yeast plasmids to include the leader sequence from the strong
yeast PMA1 promoter. A RGSH10 tag was also included for
immunodetection of expressed proteins. A new construct
containing yeALA1 under the control of the modified promoter
was transformed into Ddrs2Ddnf1Ddnf2 together with plasmids
either empty or containing a RGSH6-tagged ALIS1, ALIS3 or
ALIS5 fusion. Following isolation of yeast microsomes, tagged
proteins representing ALA1 as well as ALIS1, ALI3 and ALIS5
could now be clearly detected in protein blots (Figure 4B).
In order to compare all versions of the ALA1 gene expressed
from the same plasmid and bearing the same tag, homologous
recombination in yeast was used to generate plasmids containing
the cDNA fragments codifying for ALA1 and ALA1noTT under
the control of the GAL1-10 promoter::PMA1 leader fusion. Both
constructs were transformed into Ddrs2Ddnf1Ddnf2 together with
plasmids either empty or containing RGSH6-tagged ALIS1,
ALIS3 or ALIS5, as above. In this case, no ALA1 protein could
be immunodetected by western blot (Figure 4B), indicating that,
under our experimental conditions, modification of the codon
usage for Arg in yeALA1 was crucial for obtaining detectable
levels of expression for the protein.
In previous studies, we noted that under our working conditions
a single Ddrs2 yeast mutant shows a high incidence of genetic
revertants when tested for growth at temperatures around 20uC,
while a Ddrs2Ddnf1Ddnf2 strain is a more reliable system for testing
functional complementation of the drs2 related cold-sensitive
phenotype [26]. Moreover, translocation of natural lipids by
heterologously expressed P4 ATPases can be tested in this triple
mutant strain by growth assays on plates containing low
concentrations of cytotoxic peptides that bind to endogenous
phosphatidylserine (papuamide B) and phosphatidylethanolamine
(duramycin) [25]. When a RGSH10:yeALA1 fusion was expressed
alone in the Ddrs2Ddnf1Ddnf2 strain under the control of a
galactose-inducible promoter, the plant P4 ATPase failed both to
complement the cold-sensitive phenotype and to restore transport
of endogenous phosphatidylserine or phosphatidyletanolamine
(Figure S3). Plasma membrane localized P4 ATPases which have
phosphatidylcholine as a substrate are in some cases capable of
transporting the toxic choline ether lipid miltefosine to the interior
of the cell [17]. Employing this assay, we were unable to
demonstrate yeALA1-mediated internalization of miltefosine
(Figure S3). Identical results were obtained for an untagged
yeALA1.
A possible explanation for the apparent inability of ALA1 to
complement the phenotypes of the Ddrs2Ddnf1Ddnf2 yeast mutant
strain could be a defect in targeting of the plant protein expressed
in the yeast cells. In order to investigate whether lack of
complementation could be due to protein mistargeting in the
heterologous host, plasma membrane-enriched membrane frac-
tions from yeast expressing RGSH10-tagged ALA1 alone or
together with a representative member of the ALIS family
(RGSH6:ALIS1) were subjected to discontinuous sucrose gradient
fractionation. The results indicate that ALA1 is in fact capable of
reaching the plasma membrane when overexpressed in yeast, both
alone and with ALIS1 (Figure S4). Similar results have been
reported previously for other members of the ALA family [25,26].
Discussion
In this work we provide the first evidence for the presence of a
P4 ATPase in plant plasma membranes. In animal cells, P4
ATPases have been implicated in generation of phospholipid
asymmetry across the two bilayers of the membrane, a process
hypothesized to be a prerequisite for endocytosis and other
important functions of the plasma membrane. Expression of
fluorescently-tagged versions of ALA1 in leaves of Nicotiana
benthamiana proved that the protein is retained in the ER when
no putative b-subunit is present. Co-expression with each of three
different Arabidopsis ALIS proteins (ALIS1, ALIS3 and ALIS5)
resulted in ALA1 exit from the ER and trafficking of this protein to
the plasma membrane, demonstrating that this P4 ATPase is also
strictly dependent on interaction with a b-subunit to reach its final
subcellular localization. Moreover, when YFP-tagged versions of
the ALIS proteins (normally retained in the ER; [25]) were co-
expressed with GFP-tagged ALA1, both fluorescent signals could
be co-localized in the plasma membrane, indicating that both
proteins travel together to the destination membrane. These
results are in agreement with previous studies with Golgi-localized
ALA3 and prevacuolar compartment-localized ALA2, which
indicate that the localization determinants for the complex formed
between the P4 ATPase and its b-subunit are present in the a -
catalytic subunit [25].
We further aimed at expressing ALA1 in a Ddrs2Ddnf1Ddnf2
yeast strain, which has successfully been used before for
Figure 1. ALA1 expressed without a b-subunit localizes to the ER in planta. A GFP::ALA1 fusion was transiently expressed in tobacco
epidermal cells alone (A) or in the presence of an YFP::HDEL ER-retained marker (B). Green: GFP fluorescence; blue: autofluorescence; magenta: YFP
fluorescence; gray: bright field image. Panels on the right show an overlay image. Scale bar: 25 mm.
doi:10.1371/journal.pone.0033042.g001
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characterization of lipid translocation by the plant P4 ATPases
ALA2 and ALA3 [25,26]. After optimization of the expression
levels for ALA1 in yeast, we were successful in expressing
recombinant protein in amounts that could readily be detected
in yeast extracts by immunological methods. Following expression
of ALA1 alone and together with ALIS genes we were not able to
demonstrate functional complementation of the cold-sensitive
Drs2p-related phenotype or to recover the loss of phospholipid
asymmetry generated by deletion of the endogenous P4 ATPases
in the mutant yeast strain. This lack of complementation was not
derived from a defect in targeting of ALA1 within the yeast
trafficking machinery, as the plant P4 ATPase overexpressed in
yeast was found to reach the yeast plasma membrane both in the
presence or the absence of an ALIS b-subunit. We could not
detect any ATPase activity above background levels in membranes
from transformed yeast cells and also failed to demonstrate the
formation of an acyl-phosphate bond in the recombinant protein
(data not shown). The inability of ALA1 expression to complement
the phenotypes of the mutant yeast strain could therefore be due to
lack of functionality of the recombinant protein, for example if an
unknown factor (e.g. protein or lipid) present in plants but not in
yeast is required for ALA1 activity.
Figure 2. ALA1 localizes to the plasma membrane in the presence of an ALIS protein. A GFP::ALA1 fusion was transiently expressed in
tobacco epidermal cells in the presence of an untagged ALIS. (A,B) ALIS1; (C,D) ALIS3; (E,F) ALIS5. (A,C,E) untreated cells. (B,D,F) cells plasmolyzed
in the presence of a concentrated solution of manitol. Arrows in the bright-field and overlay images indicate the relative positions of the plasma
membrane and the cell wall in points at which they have detached (opposing arrows) or remain attached (facing arrows) during plasmolysis. The
plasma membrane is indicated with a closed arrow and the cell wall with open arrows. Green: GFP fluorescence; blue: autofluorescence; gray: bright
field image. Panels on the right show an overlay image. Scale bar: 25 mm.
doi:10.1371/journal.pone.0033042.g002
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Previously, Gomez et al. [27] demonstrated that ALA1
complements the cold-sensitive phenotype of the Ddrs2 mutant
strain [30] in the absence of a co-expressed ALIS subunit. We
made several unsuccessful attempts to reproduce the complemen-
tation in the same Ddrs2 mutant strain, in order to rule out
discrepancies due to the yeast background. This could imply that
ALA1 is not a functional homologue of yeast Drs2p. However, we
noted that this strain gives rise to an elevated number of
phenotypic revertants, especially when incubated at low temper-
atures. Revertants could arise from induction in yeast of factors
that facilitate function of recombinant ALA1. Several yeast P4
ATPases have been shown to require interaction with other
proteins for full activity. For instance, plasma membrane-localized
Dnf1p and Dnf2p are known to require phosphorylation by the
kinases Fpk1p and Fpk2p in order to be active at their final
location [31]. Another example is the interaction of Drs2p with
ARF-GEF, a small GTPase involved in vesicle production in the
TGN. This protein-protein interaction significantly stimulates lipid
translocation by Drs2p [32]. Furthermore, Drs2p activity is
dependent on the presence of a specific regulatory lipid [33].
Lack of complementation by ALA1 of the yeast P4 ATPase
deletion mutant phenotypes could therefore be due to lack of an
Figure 3. ALIS proteins co-localize with ALA1 to the plasma membrane. A GFP::ALA1 fusion was transiently expressed in tobacco epidermal
cells in the presence of YFP-tagged ALIS (ALIS::YFP). (A,B) ALIS1; C,D: ALIS3; E,F: ALIS5. A,C,E: untreated cells. B,D,F: cells plasmolyzed in the
presence of a concentrated solution of manitol. Arrows in the bright-field and overlay images indicate the relative positions of the plasma membrane
and the cell wall in points at which they have detached (opposing arrows) or remain attached (facing arrows) during plasmolysis. The plasma
membrane is indicated with a closed arrow and the cell wall with open arrows. Green: GFP fluorescence; magenta: YFP fluorescence; gray: bright field
image; blue: autofluorescence. Panels on the right show an overlay image. Scale bar: 25 mm.
doi:10.1371/journal.pone.0033042.g003
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unknown factor required for protein activity, e.g. a regulatory
lipid, an activating kinase and/or other interacting proteins.
In conclusion, we have shown that ALA1 localizes to the
plasma membrane in plant cells and have a strict requirement for
a b-subunit to exit the ER and reach its final location.
Materials and Methods
In silico Analysis of DNA Sequences
Primers were designed on the basis of information contained in
the P-type ATPase database (http://traplabs.dk/patbase). The
genomic DNA sequence for the ALA1 gene and its adjacent
59UTRs was extracted from The Arabidopsis Information
Resource webpage (www.arabidopsis.org). Transcription termina-
tion signal predictions were performed online at http://harlequin.
jax.org/drupal/?q = yeastRNApred [34]. A graphical codon usage
analyzer (http://gcua.schoedl.de/) was used to identify rare
codons that might result in low levels of expression of ALA1 in
S. cerevisiae. Default parameters were selected in both cases. Two
different ALA1 modified versions were designed based in these
analyses, ALA1noTT (no transcription termination) and yeALA1
(yeast-enhanced). For ALA1noTT, a predicted transcription
termination signal sequence around 2800 bp is removed, while
yeALA1 lacks this signal and contains five silent mutations that
modify the codon usage for arginine from the plant CGG to the
yeast-favoured AGA and AGG. Figure S2 shows a comparison of
ALA1 to the mutated versions of the gene.
DNA Cloning
All Polymerase Chain Reactions (PCRs) carried out in this study
were performed using Phusion High-Fidelity DNA polymerase
(Finnzymes) under the standard conditions recommended by the
manufacturer. In the case of genomic DNA amplification, a 2%
final concentration of dimethyl sulfoxide (DMSO) was added to
the reaction mixture. A full list of the primers used and their
characteristics can be found in Table S1. Table S2 comprises a list
of the plasmids obtained by cloning PCR products into
commercially available blunt-ended vectors, including a summary
Figure 4. Expression of ALA1 in yeast requires optimization of the cDNA sequence. (A) Total membrane protein preparations (30 mg) were
run on SDS-PAGE gels and subjected to immunodetection with antibodies raised against the engineered epitope tags. Only ALIS proteins and
yeALA1 can be detected with the anti-RGSH antibody. (B) ALA1 cDNA was modified to eliminate a putative transcription termination site and five rare
codons codifying for Arg (yeALA1) and expressed alone or together with an ALIS in a yeast Ddrs2Ddnf1Ddnf2 deletion mutant. ALA1 was tagged at
the N-terminal end with an RGSH10-tag while ALIS proteins bear a RGSH6-tag at the same end. ALA1 and ALA1noTT (ALA1 cDNA codified to eliminate
a putative transcription termination site) were also expressed under the same conditions. Total membrane protein preparations (30 mg) were run on
SDS-PAGE gels and subjected to immunodetection with antibodies raised against the engineered epitope tags. Bands corresponding to ALIS proteins
are immunodecorated with an anti-RGSH antibody, while an anti-HA antibody cannot recognize any band corresponding to HA-tagged ALA1.
doi:10.1371/journal.pone.0033042.g004
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of the primers and templates used for amplification. In some cases,
an overlapping PCR strategy was used to introduce modifications
in the original gene sequence (e.g. eliminate a predicted
transcription termination site) or to generate gene fusions (e.g.
ALA1::GFP under the control of the ALA1 promoter). In these
cases, a first round of PCR amplifications was carried out to obtain
overlapping fragments containing the desired modifications. In a
second round, 1–2 mL of each of these PCR reactions were mixed
together and used as template with primers that amplify the full-
length product. The pENTRTM/D-TOPOH Cloning Kit and the
Zero BluntH TOPOH PCR Cloning Kit for Sequencing were used
for introducing the PCR fragments into the GatewayH-compatible
vector pENTRTM/D-TOPOH (Invitrogen) and pCR4HBlunt-
TOPOH vector (Invitrogen), respectively. All PCR products were
fully sequenced in these plasmids before further cloning. Tables S3
and S4 contain a summary of all yeast and plant plasmids,
respectively, generated in this work.
For expression in yeast, the cDNA sequence corresponding to
ALA1 (At5g04930) was PCR amplified both in untagged and
hemaglutinin (HA) epitope-tagged forms and cloned into
pENTRTM/D-TOPOH. GatewayH technology was then used to
transfer the ALA1-codifying sequences to a GatewayH-compatible
version of yeast plasmid pRS423-GAL [35] and its derivatives
containing RGSH6:ALIS gene fusions [26]. These plasmids bear a
bi-directional GAL1-10 promoter fusion that allows for coordinat-
ed expression of two genes, as well as a HIS3 cassette for selection
of yeast transformants in media lacking histidine. A modified
version of ALA1 lacking a predicted transcription termination site,
ALA1noTT (see above and Figure S2), was generated by
overlapping PCR and cloned into yeast plasmids as above.
In order to increase protein expression from the GAL1-10
promoter in pRS423-GAL [35], we modified this promoter to
include the leader sequence of the yeast PMA1 gene. Pma1p is a
yeast plasma membrane H+-ATPase, which can represent up to
15% of the total protein at this membrane [36]. This high level of
expression is dependent on the strong constitutive PMA1
promoter. A piece of 238 bp of this PMA1 promoter from the
transcription start point to the start codon [37] was fused to the
GAL10 side of the GAL1-10 promoter in plasmid pRS423-GAL
using an overlapping PCR strategy (see Tables S1 and S2 for
details). A RGSH10 epitope and a Tobacco Etch Virus (TEV)
protease cleavage site separated by a 3-glycine linker were
engineered at the end of the PMA1 leader sequence in order to
allow for immunological detection of expressed proteins. The PCR
product cloned in pCR4HBlunt-TOPOH (Invitrogen) was digested
with restriction enzymes BamHI and EcoRI and transferred to
pRS423-GAL treated with the same enzymes, generating plasmid
pMP4062. A version of this plasmid not containing the epitope tag
(pMP4075) was generated by PCR amplification of the promoter-
leader fusion with unmodified primers (see Tables S1 and S2 for
details) and cloning as above.
For further optimization of ALA1 expression in yeast, another
modified version of the gene, yeALA1 (for a description see above
and Figure S2), was produced by overlapping PCR and cloned
into the pCR4HBlunt-TOPOH vector. After full sequencing,
yeALA1 was transferred to yeast plasmids pMP4062 and
pMP4075 using restriction enzymes EcoRI and SalI. In order to
introduce other versions of the ALA1 gene in these modified yeast
plasmids, the clones containing ALA1 and ALA1noTT in the
pRS423-GAL backbone (pMP3560 and pMP3647, respectively,
see Table S3) were digested with AgeI and BlpI. After DNA
electrophoresis on agarose gels, the approximately 9 kb long
fragment was isolated using a Gel AdvancedTM Gel Extraction
System (Viogene, Taiwan). This eliminates part of the promoter
and a fragment of around 170 bp of the ALA1 gene. The
linearized plasmids were transformed into a wild type yeast strain
(see below) together with a PCR fragment containing the full
length GAL1-10 promoter::PMA1 leader fusion and the first 250 nt
of the ALA1 gene both in tagged and untagged versions (see Tables
S1 and S2 for details on the PCR strategy). After homologous
recombination, plasmid DNA was extracted from the yeast cells by
heating at 95uC for 4 min in the presence of 0.2% sodium dodecyl
sulfate (SDS). After removal of cellular debris by centrifugation,
1 mL of the supernatant was used for electroporation of E. coli cells.
Amplified plasmids were tested by restriction and sequenced to
ensure the integrity of the DNA construct. Further yeast
transformations for functional characterization (see below) were
carried out with these sequenced plasmids.
Introduction of ALA1 and ALA1noTT (both in HA-tagged and
untagged versions) into yeast plasmids already containing
RGSH6-tagged versions of ALIS (see above) had proven to be a
tedious task and mutations in both the ALA1 and the ALIS gene
sequences were often occurring during the cloning process,
suggesting a toxic effect of these constructs for E. coli cells. In
order to ease the cloning process, a two-plasmid transformation in
yeast was used for co-expression of new ALA1 constructs with ALIS
genes. For this purpose, plasmids containing RGSH6:ALIS in the
pRS423-GAL backbone [26] were digested with BamHI and SacI
and the 1-kb fragments corresponding to the tagged ALIS were
ligated into pRS426-GAL [35] treated with the same enzymes.
This plasmid contains the bi-directional GAL1-10 promoter and a
URA3 cassette for selection of transformants on media lacking
uracil.
For expression of ALA1 in planta, the genomic DNA fragments
corresponding to ALA1 and 2 kb of its adjacent 59UTR sequences
were cloned by PCR from a total genomic DNA preparation (see
Tables S1 and S2 for details). After cloning into pCR4HBlunt-
TOPOH vector as described above, the new plasmids were used as
templates in an overlapping PCR to generate an ALA1
promoter::ALA1 genomic DNA::GFP fusion, that bears artificial
restriction sites XhoI and BstEI at the 59- and 39-ends, respectively.
The DNA fusion digested with XhoI and BstEI was cloned into
pCAMBIA1302 (CAMBIA, Brisbane, Australia) digested with SalI
and BstEI. To clone ALA1 under the control of a double 35 S
promoter, which should increase expression levels, new PCR
amplifications were carried out to clone the genomic DNA
fragment into vector pENTRTM/D-TOPOH as described above.
Two individual PCR products containing or lacking a stop codon
were obtained. GatewayH technology was used to further clone
these products into pMDC43 or pMDC83 [28] to generate N- or
C-terminal end fusions of GFP to ALA1.
Yeast Strains and Media
Wild type S. cerevisiae strain w303-1a (Mat a ade2-1 can1-100 his3-
11,15 leu3,112 trp1-1 ura3-1) was used for cloning different versions
of ALA1 into yeast plasmids by homologous recombination (see
above). Functional complementation was carried out employing S.
cerevisiae mutant strain ZHY709 (MATa his3 leu2 ura3 met15 dnf1D
dnf2D drs2::LEU2; [38]). Cells were grown at 30uC in standard rich
medium with glucose (YPD) or galactose (YPG), or selective SD or
SG media [39] containing Yeast Synthetic Drop-out Medium
Supplement without the required amino acids (Sigma). Solid
media were added 2% agar [40]. Papuamide B (Flintbox, Lynsey
Huxham), duramycin (Sigma-Aldrich), and miltefosine (Calbio-
chem) were added to rich synthetic SD or SG media to final
concentrations 0.05 mg/mL, 1.5 mM and 2.5 mg/mL, respectively.
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Yeast Transformation and Growth
Yeast cells were transformed by the lithium acetate method
[41]. Transformants were incubated in liquid SG medium for 4 h
and then diluted with water to OD600 0.05 and 0.005. Drops
(5 mL) were spotted on plates and incubated at 20uC for 6–8 days
(cold) or at 30uC for 2–3 days. All experiments were repeated
independently at least three times. For isolation of total membrane
protein fractions for immunodetection, 30–40 yeast colonies
transformed with the desired plasmid(s) were inoculated in
100 mL of liquid SG medium in 250 mL flasks and grown at
30uC with 140 rpm shaking. After 24 hurs growth, cells were
inoculated in 1 L of fresh SG medium in 2 L flasks and allowed to
grow under the same conditions for a further 24 hours.
Yeast Membrane Preparation and Protein
Immunodetection
Isolation of total cellular yeast membranes for protein
expression analysis was performed as previously described [40].
Discontinuous sucrose gradient fractionation of plasma mem-
brane-enriched membrane fractions was carried out essentially as
described in [25] except that cells were grown for 24 hours (28oC,
160 rpm) in 50 mL selective SG media and then inoculated
without washing into 500 mL fresh selective SG media before
incubation for further 16 hoursF under the same conditions prior
to membrane preparation. Protein samples were quantified by the
method of Bradford using bovine serum albumin (BSA) as a
standard. For protein blot analysis of membrane fractions, 30 mg
total protein were precipitated with trichloroacetic acid (TCA),
loaded onto SDS-PAGE gels, transferred to nitrocellulose
membranes and immunodetected as previously described [26].
Detection of HA- and histidine (RGSH6 or RGSH10)-tagged
proteins was carried out using a monoclonal anti-HA antibody
(Sigma) and an anti-RGSHis antibody BSA-free (Qiagen),
respectively. Dpm1p was immunodetected using an anti-dolichol
phosphate mannose synthase antibody (Molecular Probes), Sed5p
with affinity-purified anti-Sed5p [42] and Pma1p with a polyclonal
antibody raised against its C terminus [43]. Bands were visualized
with the 5-bromo-4-chloro-3-indolyl phosphate/nitroblue tetrazo-
lium (BCIP/NBT) color development substrate (Promega).
Transient Expression in Tobacco Epidermal Leaf Cells
Agrobacterium tumefaciens strain C58C1 [44] was transformed by
electroporation and transformants selected on YEP plates (1%
yeast extract, 2% peptone, 1.5% agar) containing 25 mg/mL
gentamycin and 50 mg/mL kanamycin. Transient expression in
tobacco epidermal cells was carried out as described [25] using
three week old N. benthamiana plants. Expression was visualized 4–5
days after infiltration. Plasmolysis of epidermal tobacco cells was
achieved by infiltrating the leaves with a 1 M mannitol solution 1–
2 min prior to sample preparation for microscopic visualization.
Confocal Microscopy
A Leica TCS SP2/MP or SP5 II spectral confocal laser
scanning microscope (Leica Microsystems, Heidelberg, Germany)
with a 63x/1.2 numerical aperture water immersion objective
were used as previously described [26]. Both GFP and YFP were
excited at 488 nm and emission spectra were recorded between
495 and 510 nm for GFP (green channel) and 530 and 545 nm for
YFP (magenta channel). Sequential scanning between lines was
used to follow both fluorescent proteins at once. Autofluorescence
was visualized between 600 and 680 nm. No fluorescence bleed-
through of YFP or GFP signals was detected under our
experimental conditions (see Figure S1).
Supporting Information
Figure S1 Bleed-through control of cells expressing
GFP- and YFP-tagged proteins. A GFP::ALA1 fusion was
transiently expressed in tobacco epidermal cells in the presence of
an YFP tagged ALIS3. The image shows plasmolyzed cells
subjected to osmotic shock in the presence of a concentrated
mannitol solution. (A) Green: GFP fluorescence; (B) magenta: YFP
fluorescence; (C) gray: bright field image. (D) overlay image. Two
adjacent cells containing only GFP or only YFP signals are shown.
In the upper part of the image, a cell containing both signals can
be seen. Scale bar: 25 mm.
(TIF)
Figure S2 Alignment showing a comparison between
ALA1 cDNA and the modified version used in for
increasing expression of the protein in yeast. The
unmodified ALA1 cDNA is highlighted in yellow. Silent mutations
are highlighted in red (modification of 5 codons codifying for
arginine and deletion of restriction sites) or magenta (elimination
of a putative transcription termination signal).
(TIF)
Figure S3 ALA1 fails to complement the phenotypes of a
yeast Ddrs2Ddnf1Ddnf2 mutant strain. A version of the
ALA1 cDNA modified to eliminate a putative transcription
termination site and five rare codons codifying for Arg (yeALA1)
was expressed alone or together with an ALIS in yeast lacking the
three endogenous P4 ATPases Drs2p, Dnf1p and Dnf2p. yeALA1
was expressed untagged or was tagged at the N-terminal end with
an RGSH10-tag while ALIS proteins bear a RGSH6-tag at the
same end. Left to right: glucose: control showing uninduced cells;
galactose: control plate grown under standard conditions; 20uC: cells
grown on galactose at the restrictive growth temperature;
duramycin: cells grown on galactose plates containing 1.5 mM of
the phosphatidylethanolamine-binding cytotoxic peptide duramy-
cin; Pap. B: cells grown on galactose plates containing 0.05 mL/mL
of the phosphatidylserine-binding cytotoxic peptide papuamide B;
miltefosine: cells grown on galactose plates containing 2.5 mL/mL of
the cytotoxic choline ether lipid miltefosine.
(TIF)
Figure S4 ALA1 reaches the plasma membrane when
expressed in yeast. PM-enriched membranes from yeast
expressing RGSH10:ALA1 alone or RGSH10:ALA1 together with
RGSH6:ALIS1 were subjected to discontinuous sucrose density
gradient fractionation. Fractions corresponding to 30 and 48%
sucrose, enriched respectively in endomembranes (ER, Golgi) and
plasma membranes, were analyzed. Western blots were probed
using the following antibodies: anti-Pma1p, plasma membrane;
anti-Sed5p, Golgi apparatus; anti-Dpm1p, ER; and anti-RGSHis,
ALA1 and ALIS1.
(TIF)
Table S1 PCR Primers used in this work. Standard PCR
was used to amplify the ALA1 genomic and cDNA fragments and
the ALA1 promoter region. Overlapping PCR strategies were
designed to modify the ALA1 cDNA fragment and the plasmid
used for overexpression in yeast, as well as to generate a fusion of
the ALA1 genomic fragment to its natural promoter for in planta
expression. See Materials and Methods for further details.
Artificial restriction sites before the ATG start codon or after the
stop codon are marked in bold; Epitope tags are mark in bold and
italics; New restriction sites generated by silent mutation within the
codifying sequence are written in italics; Restriction sites (in
brackets) and transcription termination sites eliminated by silent
mutations are written in italic lowercase letters; Silent mutations
Plant Plasma Membrane P4 ATPase
PLoS ONE | www.plosone.org 8 April 2012 | Volume 7 | Issue 4 | e33042
that generate modifications of the codon usage are written in
lowercase letters; The CACC sequence included at the beginning
of some oligos is a requirement for cloning in the GatewayH-
compatible vector pENTRTM/D-TOPOH.
(DOC)
Table S2 Plasmids generated by cloning of PCR prod-
ucts into commercial blunt-ended plasmids. ALA1 no TT:
modified ALA1 gene in which a predicted transcription termina-
tion signal has been deleted; yeALA1: modified ALA1 gene in
which a predicted transcription termination signal has been
deleted and several codons codifying for arginine have been
substituted to match the yeast preferred codon usage (see Materials
and Methods and FigureS2). In some cases, the final PCR
products have been generated by overlapping PCR. In these cases,
the subsequent PCR amplification rounds are named PCR1
(gegneration of overlapping fragments) and PCR2 (amplification
of the full-length final product). Letters A to E in PCR1 refer to the
different fragments generated in individual PCR reactions during
the first amplification round.
(DOC)
Table S3 Plasmids generated for expression of ALA1
and ALIS proteins in S. cerevisiae. ALA1 no TT: modified
ALA1 gene in which a predicted transcription termination signal
has been deleted; yeALA1: modified ALA1 gene in which a
predicted transcription termination signal has been deleted and
several codons codifying for arginine have been substituted to
match the yeast preferred codon usage (see Materials and Methods
and Figure S2).
(DOC)
Table S4 Plasmids for expression of fluorescently-
tagged ALA1 in planta.
(DOC)
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